Medications

Unusual combo reduces health risk from atypical antipsychotic

Atypical antipsychotics, though effective for treating disorders like schizophrenia, bipolar disorder, and depression, gives patients a heightened risk of developing new-onset diabetes. A new data mining study, however, has ...

Diabetes

Teens with autism more likely to develop type 2 diabetes

(HealthDay)—Adolescents and young adults with autism spectrum disorder (ASD) are more likely to develop type 2 diabetes mellitus (T2DM), according to a study published online March 22 in Diabetes Care.

Medications

Aristada approved for schizophrenia

(HealthDay)—Aristada (aripiprazole lauroxil) extended release injection has been approved by the U.S. Food and Drug Administration to treat the disabling brain disorder schizophrenia, the agency said Tuesday in a news release.

Medications

First generic Abilify approved

(HealthDay)—The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

Diseases, Conditions, Syndromes

Atypical antipsychotics up renal injury risk in seniors

(HealthDay)—Use of atypical antipsychotic drugs is associated with increased risk of acute kidney injury (AKI) in older adults, according to research published in the Aug. 19 issue of the Annals of Internal Medicine.

page 2 from 4